Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Scope Fluidics
Market Cap: zł411.6m
A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland.
SCP
zł151.00
7D
-1.3%
1Y
-13.7%
Medicalgorithmics
Market Cap: zł256.3m
Provides cardiac diagnostic solutions in Poland, the United States, and internationally.
MDG
zł25.75
7D
-1.0%
1Y
-4.2%